Cross Country Healthcare, Inc.
NASDAQ:CCRNMedical - Care Facilities
+$0.01 today
- Market cap
- $428.06M
- Beta
- 0.45
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.13
Volume 1.78M
Average 0.64M
CCRN Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Cross Country Healthcare, Inc.NASDAQ: CCRN
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -$9.04M, compared with $3.58M a year earlier. Trailing-twelve-month accounts receivables was $44.1M.
Context
- Accounts receivables amounted to 5.4% of revenue in FY2025, down 4.2 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$9.04M or moves back toward the trailing-twelve-month quarterly average of $11.03M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 56.73M USD
- Year-over-year change
- -55.8%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 56.73M | -55.8% |
| FY2024 | 2024-12-31 | 128.33M | -49.0% |
| FY2023 | 2023-12-31 | 251.43M | +264.1% |
| FY2022 | 2022-12-31 | (153.23M) | +51.9% |
| FY2021 | 2021-12-31 | (318.42M) | — |
Accounts Receivables vs competitors
How CCRN compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +257.7% is the highest of 8, against a peer median of -18.8%.
- Accounts receivables amounts to 4.4% of revenue for CCRN, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AUNAAuna S.A. | LTM Mar 2026 | PEN 50.57M PEN | -83.0% | -1.5% | 1.1% |
| LTM Mar 2026 | $44.1M USD | +257.7% | — | 4.4% | |
| LTM Mar 2026 | $11.73M USD | -223.9% | -13.8% | 2.1% | |
| LTM Mar 2026 | $8.05M USD | +8.8% | +33.0% | 3.3% | |
| LTM Mar 2026 | $7.32M USD | -18.8% | +8.1% | 1.8% | |
| LTM Mar 2026 | $306K USD | +107.3% | -42.6% | 0.1% | |
| LTM Mar 2026 | $198K USD | +104.9% | -41.4% | 0.2% | |
MCTACharming Medical Limited Class A Ordinary Shares | FY2024 | $44.29K USD | -73.2% | — | 0.7% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CCRN) | — | -18.8% | -7.7% | 0.9% | |
Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 132M | 185.98M | 72.63M | (14.56M) | (94.85M) |
| Depreciation & Amortization | 9.85M | 12.58M | 18.35M | 18.2M | 16.79M |
| Deferred Income Tax | (9.93M) | 5.11M | 1.3M | (1.94M) | 10.07M |
| Stock-Based Compensation | 6.89M | 7.39M | 6.58M | 6.03M | 7.14M |
| Change in Working Capital | (237.26M) | (103.71M) | 127.48M | 87.63M | 30.47M |
| Accounts Receivables | (318.42M) | (153.23M) | 251.43M | 128.33M | 56.73M |
| Inventory | (83.29M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 83.29M | 0 | (126.61M) | (29.75M) | 0 |
| Other Working Capital | 81.16M | 49.52M | 2.66M | (10.95M) | (26.26M) |
| Other Non-Cash Items | 12.82M | 26.7M | 22.16M | 24.77M | 78.63M |
| Operating Cash Flow | (85.62M) | 134.05M | 248.5M | 120.12M | 48.25M |
| Capital Expenditures | (7.17M) | (8.79M) | (13.97M) | (8.71M) | (8.16M) |
| Acquisitions (Net) | (26.88M) | (35.09M) | 199K | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (34.05M) | (43.87M) | (13.78M) | (8.71M) | (8.16M) |
| Debt Repayment | 127.68M | 32.34M | (150.68M) | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.23M) | (35.29M) | (57.65M) | (37.31M) | (6.83M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (6.35M) | (84.65M) | (12.91M) | (9.54M) | (6.17M) |
| Financing Cash Flow | 119.09M | (87.6M) | (221.24M) | (46.85M) | (13.01M) |
| Effect of Forex Changes | 6K | (9K) | 8K | (14K) | 21K |
| Net Change in Cash | (564K) | 2.57M | 13.49M | 64.54M | 27.11M |
| Free Cash Flow | (92.79M) | 125.26M | 234.52M | 111.4M | 40.09M |
Cross Country Healthcare, Inc.
NASDAQ:CCRN
Intrinsic Alpha fair value
Locked
Current Price
$13.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.